"Investigador por México" researcher specialized in the development of innovative therapies for childhood cancer. His research analyzes biochemical, structural, and functional alterations derived from post-translational protein modifications to propose them as therapeutic targets, focusing primarily on the glycolytic pathway and the Non-Neuronal Cholinergic System, without ruling out the exploration of other relevant molecular pathways. Through the integration of advanced cellular models and patient clinical samples, his work aims to discover new pharmacological targets and advance translational medicine to improve therapeutic options in pediatric oncology.
"Investigador por México" researcher specialized in the development of innovative therapies for childhood cancer. His research analyzes biochemical, structural, and functional alterations derived from post-translational protein modifications to propose them as therapeutic targets, focusing primarily on the glycolytic pathway and the Non-Neuronal Cholinergic System, without ruling out the exploration of other relevant molecular pathways. Through the integration of advanced cellular models and patient clinical samples, his work aims to discover new pharmacological targets and advance translational medicine to improve therapeutic options in pediatric oncology.